{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:30:38Z","timestamp":1740807038839,"version":"3.38.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.brachy.2024.10.016","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T21:56:39Z","timestamp":1735077399000},"page":"238-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of dose distribution to the tumor and organs at risk for cervical cancer patients treated using HDR-ICBT without central tandem applicator: A single center based experience"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1000-8614","authenticated-orcid":false,"given":"Jonasi A.","family":"Foya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mwingereza J.","family":"Kumwenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0673-4665","authenticated-orcid":false,"given":"Khamis O.","family":"Amour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jofrey J.","family":"Masana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2024.10.016_bib0001","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3892\/ol.2020.11754","article-title":"Cervical cancer in low and middle income countries (review)","volume":"20","author":"Hull","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.brachy.2024.10.016_bib0002","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.brachy.2024.10.016_bib0003","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.gore.2019.05.008","article-title":"Cervical cancer in Tanzania: A systematic review of current challenges in six domains","volume":"29","author":"Runge","year":"2019","journal-title":"Gynecol. Oncol. Reports"},{"key":"10.1016\/j.brachy.2024.10.016_bib0004","doi-asserted-by":"crossref","first-page":"64","DOI":"10.6004\/jnccn.2019.0001","article-title":"Cervical cancer, version 3.2019","volume":"17","author":"Koh","year":"2019","journal-title":"JNCCN J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.brachy.2024.10.016_bib0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/OLQ.0b013e31823b50ad","article-title":"Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the General population of Tanzania: the PROTECT study","volume":"39","author":"Dartell","year":"2012","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.brachy.2024.10.016_bib0006","first-page":"1","article-title":"Some traits on the outcome of the treatment of cervical Cancer in Tanzania: A case study of Ocean Road Cancer Institute (ORCI)","volume":"21","author":"Bakari","year":"2019","journal-title":"Tanzan. J. Health Res."},{"key":"10.1016\/j.brachy.2024.10.016_bib0007","first-page":"475","article-title":"Comparison of prescribed from delivered dose to cancer of cervix patients treated by Theratron Equinox 80 cm source-to-axis distance (SAD) technique at Ocean Road Cancer Institute in Tanzania","volume":"46","author":"Amour","year":"2020","journal-title":"Tanzania J. Sci."},{"key":"10.1016\/j.brachy.2024.10.016_bib0008","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brachy.2011.07.002","article-title":"American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.10.016_bib0009","first-page":"116","article-title":"Implementation of high dose rate brachytherapy in limited resource settings","volume":"30","year":"2015","journal-title":"IAEA Hum. Heal. Ser. No."},{"key":"10.1016\/j.brachy.2024.10.016_bib0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.31557\/apjcc.2022.7.1.85-90","article-title":"Dosimetric analysis and effect of different definitions of prescription point \u201cA\u201d in high dose rate brachytherapy for cervical cancer","volume":"7","author":"Agrawal","year":"2022","journal-title":"Asian Pacific J. Cancer Care"},{"key":"10.1016\/j.brachy.2024.10.016_bib0011","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1259\/0007-1285-26-305-252","article-title":"Treatment of cancer of the cervix uteri-a revised \u201cManchester method","volume":"26","author":"Tod","year":"1953","journal-title":"Br J. Radiol"},{"key":"10.1016\/j.brachy.2024.10.016_bib0012","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.7314\/APJCP.2014.15.13.5259","article-title":"CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder","volume":"15","author":"Hashim","year":"2014","journal-title":"Asian Pacific J. Cancer Prev."},{"key":"10.1016\/j.brachy.2024.10.016_bib0013","first-page":"11","article-title":"Comparison of dose volume histograms and international commission of radiation units and measurement point doses to bladder and rectum in carcinoma cervix patients treated with intracavitary brachytherapy in department of radiotherapy","volume":"4","author":"Priya","year":"2022","journal-title":"Sci. Med. Sci."},{"key":"10.1016\/j.brachy.2024.10.016_bib0014","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/IGC.0b013e3181b62e73","article-title":"Increasing brachytherapy dose predicts survival for interstitial and tandem-based radiation for stage IIIB cervical cancer","volume":"19","author":"Viswanathan","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.brachy.2024.10.016_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/IGC.0b013e31823ae3c9","article-title":"The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in Radiation Therapy Oncology Group prospective trials 0116 and 0128","volume":"22","author":"Viswanathan","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.brachy.2024.10.016_bib0016","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0360-3016(01)01755-2","article-title":"The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix","volume":"52","author":"Nag","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2024.10.016_bib0017","first-page":"177","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis","volume":"128","author":"Gon\u00e7alves","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.brachy.2024.10.016_bib0018","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brachy.2016.10.007","article-title":"American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries","volume":"16","author":"Suneja","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.10.016_bib0019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0971-6203.39417","article-title":"Dosimetric evaluation of rectum and bladder using image-based CT planning and orthogonal radiographs with ICRU 38 recommendations in intracavitary brachytherapy","volume":"33","author":"Jamema","year":"2008","journal-title":"J. Med. Phys."},{"key":"10.1016\/j.brachy.2024.10.016_bib0020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.brachy.2008.05.005","article-title":"Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data","volume":"7","author":"Yaparpalvi","year":"2008","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.10.016_bib0021","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.prro.2019.06.003","article-title":"Appropriate methodology for EBRT and HDR intracavitary\/interstitial brachytherapy dose composite and clinical plan evaluation for patients with cervical cancer","volume":"9","author":"Xu","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.10.016_bib0022","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.brachy.2024.10.016_bib0023","first-page":"48","article-title":"Clinical and Translational Radiation oncology the EMBRACE II study\u202f: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.brachy.2024.10.016_bib0024","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijrobp.2006.01.036","article-title":"The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results","volume":"65","author":"Kirisits","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.brachy.2024.10.016_bib0025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1754-9485.2011.02272.x","article-title":"A comparison of ICRU point doses and volumetric doses of organs at risk (OARs) in brachytherapy for cervical cancer","volume":"55","author":"Vinod","year":"2011","journal-title":"J. Med. Imaging Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.brachy.2024.10.016_bib0026","article-title":"Dose evaluation of organs at risk (OAR) cervical cancer using dose volume histogram (DVH) on brachytherapy","volume":"853","author":"Wibowo","year":"2017","journal-title":"J. Phys. Conf. Ser."},{"key":"10.1016\/j.brachy.2024.10.016_bib0027","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.clon.2010.05.020","article-title":"Delivery of brachytherapy for cervical cancer: organisational and technical advice to facilitate high-quality care","volume":"22","author":"Morton","year":"2010","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.brachy.2024.10.016_bib0028","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.17576\/jsm-2015-4408-10","article-title":"Evaluation of organ at risk (OAR) doses based on 2D treatment planning in intracavitary brachytherapy of cervical cancer","volume":"44","author":"Abdullah","year":"2015","journal-title":"Sains Malaysiana"},{"key":"10.1016\/j.brachy.2024.10.016_bib0029","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1259\/bjr\/33762931","article-title":"Changes in applicator positions and dose distribution between high dose rate brachytherapy fractions in cervix carcinoma patients receiving definitive radiotherapy","volume":"79","author":"Garipa\u01e7ao\u01e7lu","year":"2006","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.brachy.2024.10.016_bib0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5114\/jcb.2012.30678","article-title":"Non isocentric film-based intracavitary brachytherapy planning in cervical cancer: a retrospective dosimetric analysis with CT planning","volume":"4","author":"Tyagi","year":"2012","journal-title":"J Contemp Brachytherapy"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124004501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124004501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:38:10Z","timestamp":1740746290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472124004501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1538472124004501"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2024.10.016","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of dose distribution to the tumor and organs at risk for cervical cancer patients treated using HDR-ICBT without central tandem applicator: A single center based experience","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2024.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}